Intermittent fasting (IF) — cycling between periods of eating and fasting — has robust evidence supporting longevity benefits across multiple model organisms, with emerging human data confirming many of the proposed mechanisms.
What Does the Research Say?
Studies in yeast, worms, flies, and mammals consistently show that caloric restriction and fasting extend lifespan by 15–40%, primarily through autophagy induction, mTOR inhibition, and improved mitochondrial function. In humans, clinical trials demonstrate that time-restricted eating (typically 16:8 or 18:6 protocols) reduces fasting insulin, improves cardiometabolic markers, reduces inflammatory cytokines, and lowers blood pressure.
A 2019 study in Cell Metabolism found a 5-day fasting-mimicking diet performed monthly for 3 months reduced multiple aging risk factors simultaneously. The CALERIE trial — a 2-year caloric restriction study in non-obese humans — confirmed that CR reduces markers of metabolic disease and systemic inflammation even in people who are not overweight.
Key Findings
- Autophagy induction during fasting removes damaged cellular components — a core longevity mechanism
- Time-restricted eating improves cardiometabolic biomarkers associated with healthy aging
- Monthly fasting-mimicking diet cycles reduce multiple aging risk factors in clinical trials
- Combines favorably with exercise, rapamycin, and other longevity interventions mechanistically
Practical Takeaway
The most evidence-backed approach is daily time-restricted eating (16:8: eating within an 8-hour window). Protein and nutrient adequacy during the eating window is critical — fasting without sufficient protein risks muscle loss, particularly in older adults. Front-load calories earlier in the day to align with circadian rhythms for added benefit.